Sanofi (SNY) EBT (2009 - 2026)

Sanofi has disclosed EBT across 18 years of filings, most recently posting $1.6 billion for Q2 2026.

• In Q2 2026, EBT fell 15.76% year-over-year to $1.6 billion; the TTM figure through Jun 2026 stood at $9.0 billion (down 16.69% YoY), while the FY2025 annual figure was $7.2 billion, down 24.91% from the prior year.
• EBT came in at $1.6 billion for Q2 2026 at Sanofi, down from $2.8 billion in the prior quarter.
• In the past five years, EBT ranged from a high of $9.7 billion in Q3 2025 to a low of -$5.0 billion in Q4 2025.
• Average EBT over 5 years is $3.2 billion, with a median of $2.7 billion recorded in 2025.
• Year-over-year, EBT soared 43488.98% in 2022 and sank 368.88% in 2025.
• Over 5 years, EBT stood at $7.2 billion in 2022, then rose by 24.83% to $9.0 billion in 2023, then sank by 79.32% to $1.9 billion in 2024, then tumbled by 368.88% to -$5.0 billion in 2025, then soared by 132.6% to $1.6 billion in 2026.
• Per Business Quant data, the three most recent EBT figures were $1.6 billion in Q2 2026, $2.8 billion in Q1 2026, and -$5.0 billion in Q4 2025.